Kiro Grifols, part of the Grifols group, is an established provider of automated IV compounding solutions, with a proven track record of more than 50 installations worldwide. This global installed base demonstrates the adaptability of our technologies to regulatory requirements across different countries and continents, as well as to diverse hospital information systems, workflows, and operating models. Kiro Grifols combines automation capabilities to address a wide range of aseptic production needs, from patient-specific preparations to the standardized, semi-industrial-scale production of hazardous oncology medications and non-hazardous therapies, supported by Grifols’ extensive expertise in aseptic manufacturing.
Founded in Barcelona in 1909, Grifols is a global healthcare company committed to improving health and well-being. A leader in plasma-derived medicines and transfusion medicine, it provides innovative healthcare solutions and services in more than 110 countries.
Visit Website